Movetis NV is a biotechnology and healthcare startup that was founded in 2006. The company received its last investment of €49.00M in a Series A funding round on 08 January 2007. The investors involved in this round were Sofinnova Partners, Life Science Partners, Sofinnova Investments, GIMV, Quest for Growth, BIP Investment Partners, and KBC.
Movetis NV
Founded 2006
6 employees
Series A
Total: $49.00M
Biotechnology, Health Care
General Information
Company Name
Movetis NV
Founded Year
2006
Employees
6
Industries
Biotechnology, Health Care
Funding Stage
Series A
BounceWatch is an independent company data service, not affiliated with Movetis NV. To contact Movetis NV, visit movetis.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Movetis NV compare?
A PDF of Movetis NV and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Movetis NV soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Movetis NV
Business keywords: pharmaceutical company, drug discovery, gastrointestinal disorders, chronic constipation, GI motility disorders, ascites, paediatric reflux, symptomatic treatment, Resolor, M0002, M0003, clinical trials, drug development, partner universities, Belgium headquarters
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | €49.00M | 7 |
|
08 Jan 2007 |
| Venture Round | Undisclosed | 1 |
|
01 Jan 2006 |
Movetis NV Alternatives & Competitors
View All Alternatives
Movetis NV vs
Pioneering advancements in neuropsychiatric treatment for a brighter future
Series B
11-50 employees
Biotechnology, Health Care
Movetis NV vs
Neurolixis
United States
New treatments for central nervous system disorders
Seed
5 employees
Biopharma, Biotechnology
Movetis NV vs
Bilayer Therapeutics
United States
Developing innovative treatments for GI disease and metabolic disorders (obesity & diabetes) based o...
Venture round
1 employees
Biotechnology, Health Care
FAQ About Movetis NV
See website
Movetis NV was founded in 2006.
Movetis NV operates in Biotechnology and Health Care. Its work centres on pharmaceutical company, drug discovery, gastrointestinal disorders and chronic constipation.
Movetis NV has approximately 6 employees.
Movetis NV has completed 2 funding rounds, raising a total of $49.00M. The latest funding stage is Series A.
Top alternatives and competitors to Movetis NV include Chase Pharmaceuticals, Neurolixis, Bilayer Therapeutics, Atlantic Healthcare, RogCon, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Movetis NV and Chase Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Movetis NV, https://bouncewatch.com/company/movetis-nv, updated 27 October 2024. When citing, please name BounceWatch and link this page.
